AbbVie stock price jumps 3% into weekend as $8 billion bond sale nears settlement
AbbVie shares rose 3.29% to $232.08 on Friday, outperforming a falling U.S. market. The company plans to raise about $7.95 billion through a seven-part bond sale settling March 4, according to SEC filings. General counsel Perry C. Siatis sold 22,381 shares at $230 after exercising options.